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Abbreviations 
 
TDI: tissue Doppler imaging 
2D: 2-dimensional  
PIV: particle image velocimetry 
BNP: B-type natriuretic peptide 
PAH: pulmonary arterial hypertension 
CTD: connective tissue diseases 
PAP: pulmonary artery pressure 
HCM: hypertrophic cardiomyopathy 
E’: early diastolic myocardial longitudinal velocity 
A’: late diastolic myocardial longitudinal velocity 
S: systolic myocardial longitudinal velocity  
E: early diastolic velocity of the mitral inflow 
A: late diastolic velocity of the mitral inflow 
DT: deceleration time of the E wave  
IVRT: isovolumic relaxation time 
RVFAC: right ventricular fractional area change 
PCWP: pulmonary capillary wedge pressure 
PVR: pulmonary vascular resistance 
ANOVA: analysis of variance 
BSA: body surface area 
EF: ejection fraction 
RV: right ventricle 
RS: relative strength 
VRS : vortex relative strength 
VPC: vortex pulsation correlation 
EDWT: end-diastolic wall thickness 
LV: left ventricular 
EDV: end-diastolic volume 
LA: left atrial 
 5
MV: mitral valve 
ω: vorticity 
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1. Introduction 
 
1.1. Development of special echocardiographic techniques 
Heart failure is a complex clinical syndrome that can result from any structural or functional 
cardiac disorder that impairs the ability of the ventricle to fill with or eject blood. The 
syndrome of heart failure is a common manifestation of the later stages of various 
cardiovascular diseases, including coronary artery disease, systemic or pulmonary 
hypertension, valvular disease and primary myocardial disease. Echocardiography, what is the 
most frequently performed cardiovascular examination after electrocardiography, has 
revolutionized the diagnosis of heart failure. By the help of the common echocardiographic 
techniques – M-mode, 2-dimensional echocardiography and conventional Doppler – essential 
information regarding cardiac morphology, function and hemodynamics can be obtained non-
invasively. Several challenging problems, however, required the further development of the 
echocardiographic technique.  
The overall function of the left ventricle depends on a normal contraction of the longitudinally 
and circumferentially orientated myocardial fibers.1 Quantitation of the left ventricular 
function in the longitudinal axis may be clinically relevant since the contraction in this 
direction is mainly due to subendocardial fibers. As the apex of the heart remains remarkably 
stationary, long axis changes are reflected in movements of the base of the heart. The first 
detailed data on the analysis of the myocardial dynamics of the heart with the use of pulsed 
tissue Doppler imaging (TDI) by locating the sample volume at the basal segment of the 
posterior wall were reported in 1989.2 By now, TDI has become a validated technique for 
assessing both regional and global systolic and diastolic myocardial longitudinal function. 
Major limitation of the TDI technique is, that cannot differentiate between active and passive 
movement of a myocardial segment.  Myocardial deformation analysis (strain and strain rate) 
is more useful for detection of regional myocardial dysfunction. Because of the relationship 
between myocardial motion and deformation, wall motion velocity measurements by tissue 
Doppler can be used to obtain regional and global strain and strain rate data.3 Non-Doppler 
based (2-dimensional- 2D) strain and strain rate imaging is an even newer echocardiographic 
technique for obtaining deformation measurements.4 It analyzes motion by tracking speckles 
(natural acoustic markers) in the 2D ultrasonic image. The geometric shift of each speckle 
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represents local tissue movement. When frame rate is known, the change in speckle position 
allows determination of its velocity. Thus, the motion pattern of myocardial tissue is reflected 
by the motion pattern of speckles. By tracking these speckles, strain and strain rate can be 
calculated.4While traditional and tissue Doppler echocardiography measure velocities relative 
to the transducer and therefore contain only 1-dimensional information on the blood velocity 
component towards or away from the transducer, the 2D strain method tracks not along the 
ultrasound beam, but in two dimensions, along the dimensions of the wall, and thus is angle 
independent. 
Combination of the echocardiographic speckle tracking method and the well-known optical 
imaging technique of particle image velocimetry (PIV) has made possible the development of 
a new technique for the visualization of the left ventricular flow pattern. This contrast 
echocardiography based method is angle independent and therefore is able to provide 
adequate information for the reconstruction of velocity vector field in the left ventricle.5-8  
 
1.2. Special problems in heart failure 
Cardiac biomarkers are substances that are released into the blood when the heart is damaged. 
Measurement of these biomarkers may also help in the diagnosis, evaluation, and monitoring 
patients with suspected heart failure. B-type (earlier known as “brain”) natriuretic peptide 
(BNP) has diuretic, natriuretic and vasodilator effects regulating the fluid homeostasis of the 
human body. The peptide is predominantly secreted by the ventricles of the heart in response 
to excessive stretching of the cardiomyocytes. BNP is co-secreted along with a 76 amino acid 
N-terminal fragment (NT-proBNP) which is biologically inactive, but its biological half-life 
is longer as that of BNP, making this peptide better target than the BNP itself for diagnostic 
blood testing.9 The plasma concentration of NT-proBNP is typically increased in patients 
with asymptomatic or symptomatic left ventricular systolic dysfunction.10 In patients with 
isolated left ventricular diastolic dysfunction the NT-proBNP concentration is also elevated, 
the structural and hemodynamic factors underlying the increase, however, are less clear.11-13  
Pulmonary arterial hypertension (PAH) is a rare, but life threatening complication of   
connective tissue diseases (CTD). 14-16 Early detection of CTD patients at risk for pulmonary 
hypertension could lead to more timely intervention and thus favourably alter disease 
management. Recent studies suggest that an abnormal rise in pulmonary arterial (PA) systolic 
pressure (PASP) during exercise in CTD patients is a marker for the development of future 
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resting PAH.17-19 Several attempts have been made to find an easy method for recognising 
patients with stress induced PAH.  
The flow inside of the left ventricle represents one of the most interesting but poorly known 
problems in biological fluid dynamics. A challenging aspect of this topic is the occurrence of 
diastolic vortices within the ventricular chamber. 20 Such phenomenon has been initially 
recognised by in vitro experiments, 21 22and afterwards confirmed by numerical analysis of the 
problem.23-25 In vivo clues in the understanding of the flow features has been obtained by 
colour Doppler echocardiography 26-28 and by magnetic resonance imaging 29-30 31-32both in 
healthy subjects and under pathologic conditions. Nevertheless, a widespread available 
method to visualize and quantify left ventricular vortices has not been available so far. 
The aim of our work was to prove the usefulness of the novel echocardiographic techniques – 
TDI and echocardiographic PIV - in the solution of these special problems in heart failure 
patients. 
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2. Objectives 
  
- The aim of the study was to investigate the correlation between levels of B-type natriuretic 
peptide and the TDI and conventional Doppler echocardiographic parameters characterizing 
the global left ventricular diastolic function in patients with hypertrophic cardiomyopathy.  
 
- Based on non-invasive studies, it has been reported that isolated resting longitudinal 
diastolic dysfunction of the right ventricle may be the sign of exercise induced pulmonary 
hypertension in patients with connective tissue diseases. The aim of our work was to confirm 
this observation by the help of our results obtained from TDI measurements and right heart 
catheterisation.  
 
- We were planning to describe and distinguish left ventricular flow patterns in healthy hearts 
and in patients with different types of prosthetic mitral valves by the help of the new method 
of echocardiographic particle image velocimetry. Flow-mediated energy dissipation in the left 
ventricle was also investigated. 
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3. Relationship between conventional and tissue Doppler echocardiographic 
parameters and B-type natriuretic peptide (NT-proBNP) levels in patients 
with hypertrophic cardiomyopathy 
 
3.1. Introduction 
Hypertrophic cardiomyopathy (HCM) is a hereditary cardiac disease characterized by 
primary myocardial hypertrophy. The left ventricular cavity is narrow, ejection fraction is 
normal or supernormal. Left ventricular outflow tract obstruction caused by the hypertrophied 
interventricular septum occurs in 25% of all HCM patients. Typical symptoms of 
hypertrophic cardiomyopathy (dyspnoea, decreased exercise capacity) are strongly related to 
the degree of left ventricular diastolic dysfunction.33 While several techniques are available to 
assess left ventricular systolic function, the conventional methods to estimate the left 
ventricular diastolic function have limited value, because of their dependence on loading 
conditions.34-35 
At the same time, TDI has been reported to be a preload independent echocardiographic 
technique. Early diastolic myocardial velocity (E’) measured at the mitral annulus using TDI 
is a reliable index for evaluating left ventricular diastolic function, while longitudinal systolic 
velocity (S) is characteristic of global left ventricular systolic function. Late diastolic 
myocardial velocity (A’) is a parameter for assessing left atrial systolic function.36-38 The ratio 
of the early diastolic velocity of the mitral inflow to early diastolic velocity of the mitral 
annulus (E/E') provides a good estimate of left ventricular filling pressure.33-35, 39  
The plasma concentration of BNP and NT-proBNP is typically increased in patients with 
isolated left ventricular diastolic dysfunction, the structural and hemodynamic factors 
underlying the increase, however, are not completely clear.11-13 Patients suffering from HCM 
provide a good model to investigate the factors influencing the secretion of this biomarker in 
isolated left ventricular diastolic dysfunction. Thus the aim of our study was to determine the 
relation of diastolic mitral annular velocities combined with conventional Doppler indices to 
the NT-proBNP levels in patients with HCM. 
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3.2. Patients and methods 
3.2.1. Patient selection 
Thirty two consecutive patients suffering from HCM were studied. Table 1 outlines the 
principal characteristics of our patients. The diagnosis of HCM was based on the 
echocardiographic demonstration of unexplained left ventricular hypertrophy (maximal wall 
thickness ≥ 15 mm). Patients were selected according to the following criteria: normal sinus 
rhythm; heart rate < 90 beats/min at the time of the echocardiographic study; absence of 
mitral stenosis, severe mitral insufficiency or prosthetic mitral valve. Left ventricular ejection 
fraction was ≥ 50 %, with normal left ventricular cavity dimensions. Usual oral medication of 
the patients was not discontinued during our studies. 
All subjects had given written informed consent prior to undergoing echocardiography and 
blood sample collection. 
 
Table 1. Main clinical characteristics of the study population 
Gender 
(male/ 
female) 
Age 
(years) 
NYHA 
functional 
class 
Localization 
Outflow 
tract 
obstruction   
(> 30 
mmHg) 
Medication 
21/11  47±14 I.    3 pts. 
II. 29 pts. 
Septal 23 pts 
Apical   3 pts 
Cc.        6 pts. 
1 pts. Beta bl. 23pts. 
ACE-inh. 12 pts. 
Verapamil 5 pts. 
(Pts: patients; cc: concentric; beta bl.: beta blockers; ACE-inh.: ACE-inhibitors) 
 
3.2.2. Echocardiography 
All echocardiographic studies were performed using ATL HDI 5000 ultrasound equipment 
(Bothell, USA) by a single echocardiographer. All 2D and M-mode measurements were 
obtained from standard parasternal long- and short axis, as well as apical 4- and 2-chamber 
views. Left ventricular ejection fraction was measured by Simpson’s method. Transmitral 
flow was recorded from the apical 4-chamber view, while placing the sample volume at the 
level of the mitral valve leaflet tips. Peak of the early (E) and late (A) diastolic velocities and 
E-wave deceleration time (DT) parameters were measured, and the E/A ratio was calculated. 
 12
Isovolumic relaxation time (IVRT) was determined using pulsed Doppler echocardiography. 
The cursor was placed between the left ventricular outflow and the mitral inflow. TDI of the 
lateral and septal mitral annulus was also performed in addition to the conventional 
echocardiographic measurements. Peak of the early- (E’) and late (A’) diastolic velocities 
were measured. E/E’ ratio was calculated. Measurements were obtained from ≥ 3 consecutive 
beats. Lateral E/E’ >10 or septal E/E’ >15 were considered as elevated.39-40  
 
3.2.3. Measurement of NT-proBNP 
Patients were at rest in supine position for at least 30 min before blood sampling. Peripheral 
venous blood samples were taken from the antecubital vein at the time of the 
echocardiography. NT-proBNP levels were detected by immunoassay on the Elecsys 2010 
system (Roche Diagnostics). NT-proBNP values increase with age and are higher in women 
than in men. The following values were considered as normal: in young women (<50 years) 
<153, in older women < 334, in young men (< 50 years) < 88 and in older men < 227 pg/ml. 
Precision and analytical sensitivity of the system have already been reported.41  
 
3.2.4. Statistical analysis 
Continuous variables are presented as mean ± SD. NT-proBNP values did not show normal 
distribution, thus Spearman’s method was used to determine correlations between the 
continuous variables. Thereafter, the NT-proBNP values were transformed into a natural 
logarithm (lnNT-proBNP). Stepwise multiple linear regression analysis was performed where 
lnNT-proBNP served as dependent variable. A p value of < 0.05 was considered significant. 
Data were analyzed using SPSS 10.0 statistical software (SPSS, Chicago, Illinois).  
 
3.3. Results 
Table 2 shows the results of the echocardiographic measurements in our patients. Lateral and 
septal E/E’ indicated elevated left ventricular filling pressure in 10 (31%) and 8 (25%) 
patients, respectively.  
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Table 2. Main echocardiographic characteristics of the study population 
 
Parameters Values measured in HCM-pts 
E (cm/s) 76.6±19.8
A (cm/s) 68.9±22.2
E/A 1.2±0.4
DT (ms) 214.7±62.2
IVRT (ms) 101.0±24.5
Lat E’ (cm/s) 9.4±3.0
Lat A’ (cm/s) 9.0±2.9
E/lat E’ 9.1±4.3
Sep E’ (cm/s) 6.6±1.8
Sep A’ (cm/s) 8.0±2.1
E/sep E’ 12.5±4.8
 
 
Mean NT-proBNP level turned out to be 543±845 pg/ml. Elevated BNP level was found in 21 
patients (66%). 
NT-proBNP levels negatively correlated with the lateral (r=-0.59, p<0.001) and septal (r=-
0.391, p=0.03) A' values and showed a strong correlation with E/A as well (r=0.476, 
p=0.007). Weak, but significant correlation was found between the NT-proBNP levels and 
E/sepE’ (r=0.392, p=0.029). No significant relationship was observed between NT-proBNP 
levels and other echocardiographic parameters.  
By stepwise multiple linear regression analysis the only significant predictor of lnNT-proBNP 
was lateral A’ value, too (r=-0.467, p<0.05). (Figure 1.) 
 
3.4. Discussion 
HCM is a typical disease characterized by isolated diastolic dysfunction of the left ventricle. 
Conventional Doppler echocardiographic assessment of the mitral inflow is dependent on 
loading conditions, therefore its value is limited in the estimation of the diastolic function. 
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Figure 1. Linear regression between lateral A’ and lnNT-proBNP  
 
Doppler curves obtained from the pulmonary veins may serve as a solution for this problem. 
This measurement, however, is technically challenging, therefore has not become part of the 
daily routine.34 
Estimation of the mitral annular motion by the help of TDI is a technically simple and 
feasible supplementary method for the assessment of the global left ventricular diastolic 
function. Systolic, early- and late diastolic velocities of the TDI-curve may be obtained from 
both the lateral and septal region of the mitral annulus. Nagueh et al. reported, that in HCM 
patients lateral E’ is higher and more reproducible than septal E’, what is often very low in 
this patient-group.42 Unfortunately, the normal values of the TDI parameters are not well 
defined in the literature. Determination of the normal values by age groups seems to be 
reassuring.35  
The role of BNP is well known in the diagnosis of the systolic heart failure.10 Isolated left 
ventricular diastolic dysfunction is common in conditions such as hypertension, diabetes or 
chronic ischemic heart disease. Studies to investigate the diagnostic role of the BNP were also 
performed in these diseases. 11-13 Mottram et al. have suggested that the general diagnostic 
value of BNP is limited in patients with hypertension and consequential left ventricular 
hypertension. Nevertheless, they have found a significant inverse correlation between BNP 
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level and the late diastolic TDI parameter (A’) measured at the lateral mitral annulus.12 In 
HCM patients, Briguori et al. could not find any correlation between conventional Doppler-
echocardiographic parameters and BNP level. At the same time, they have found significant 
inverse correlation between the BNP level and left atrial fractional shortening.11 To date, 
there are no published data on the relation between BNP level and longitudinal myocardial 
function in HCM, as determined by TDI. 
The aim of our study was to investigate the correlation between NT-proBNP levels and 
conventional Doppler indices and mitral annular velocities characterizing the left ventricular 
diastolic function in patients with hypertrophic cardiomyopathy.   
According to our results the main determinant of the NT-proBNP level is the A’ parameter, 
characterizing left atrial systolic function. NT-proBNP showed a strong correlation with E/A 
as well. The latter result, however, must be interpreted carefully, because the E/A ratio does 
not show a linear correlation with the worsening of the diastolic dysfunction.  
The left atrium is a reservoir for the left ventricle during systole, a conduit during early 
diastole and an active contractile chamber in late diastole. It contributes up to 30% of left 
ventricular output.43 During diastole, the left atrium is directly exposed to left ventricular 
pressure that increases with worsening left ventricular diastolic dysfunction. Consequently, 
left atrial pressure increases in order to maintain adequate left ventricular filling.44 This 
results in increased left atrial wall tension and dilatation of the left atrium. Previous studies 
have shown a strong association of left atrial volume with left ventricular diastolic function 
grade.45-47 
In patients with impaired relaxation (mild form of diastolic dysfunction), the left atrial 
contractile function and active emptying volume is increased compared with normal, 
reflecting a compensatory mechanism. As the severity of left ventricular diastolic dysfunction 
increases (pseudonormal or restrictive filling pattern), this compensatory mechanism is lost, 
the left atrial contractile function declines parallel with the elevation of left ventricular filling 
pressure. 12, 44, 48-50 
A’ velocity reliably quantifies left atrial contractile function in late diastole.36-37. In our study, 
A’ tended to be impaired parallel with the elevation of left ventricular filling pressure, 
showing a strong inverse correlation with NT-proBNP level. 
These data suggests that the missing link between left atrial function and NT-proBNP level 
may be the left ventricular diastolic function. At the same time, no, or very weak correlations 
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were found between NT-proBNP and conventional or tissue Doppler parameters 
characterizing the global left ventricular diastolic function (DT, IVRT, E’) or left ventricular 
filling pressure (E/E’).  
Previous studies reported that BNP is secreted predominantly from the ventricle and the 
principal factor stimulating BNP synthesis and release from the ventricular cardiomyocytes is 
the increased ventricular wall stress.10 Our data, however, suggests that left atrial wall stress 
may be an additional, direct determinant of the BNP synthesis. Further studies are necessary 
to elucidate this phenomenon. In addition, the predictive value of the easily measurable A’ 
parameter should be further evaluated in larger outcome studies. 
 17
4. Echocardiographic monitoring of right ventricular function in patients 
with resting or stress induced pulmonary arterial hypertension secondary 
to connective tissue diseases 
 
4.1. Introduction 
PAH is a rare disease of small pulmonary arteries characterised by endothelial dysfunction 
and cellular proliferation throughout all vessel layers, resulting in progressively elevated 
pulmonary arterial resistance with increasing right heart strain and finally right heart failure. 
The condition may develop in CTD such as systemic sclerosis, systemic lupus erythematosus, 
mixed connective tissue disease, and to a lesser extent, rheumatoid arthritis, polymyositis and 
primary Sjögren's syndrome leading to a substantial worsening of prognosis. The survival rate 
of CTD patients with PAH is in the range of some malignant diseases and highlights the need 
for early diagnosis and treatment. 14-16 
Early detection of CTD patients at risk for pulmonary hypertension could lead to more timely 
intervention and thus favourably alter disease management. The change in PASP with 
exercise provides a possible tool for such detection. In normal individuals, PA pressures 
remain unchanged with exercise or increase slightly. Although the concept of exercise 
induced PAH has been eliminated from the recent guideline, 51 several studies suggest that an 
abnormal rise in PASP during exercise in CTD patients with or without exertional dyspnoea, 
but with normal resting PA pressures, is a marker for the development of future resting 
PAH.17-19 
The most commonly used method to identify CTD patients with exercise induced PAH is the 
exercise Doppler echocardiography. Nevertheless, a recent study based on resting pulsed-
tissue Doppler echocardiography showed that in systemic sclerosis patients a predominantly 
diastolic right ventricular dysfunction may be found, also in the presence of normal resting 
PASP, probably as the consequence of the exercise induced PAH.52 Based on stress 
echocardiography and resting TDI measurements Huez et al.53 also suggested that isolated 
resting longitudinal diastolic dysfunction of the right ventricle may be the sign of exercise 
induced pulmonary hypertension. The aim of our work was to confirm this observation by the 
help of our data obtained by TDI measurements and right heart catheterisation. 
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4.2. Methods 
4.2.2. Study population 
A total of 60 patients (mean age 54±8 years, 50 female) were enrolled into the study. These 
comprised 15 healthy subjects who had no signs or symptoms of heart disease and 45 
consecutive patients suffering from CTD of whom 40 had systemic sclerosis, 2 had systemic 
lupus erythematosus, 2 had mixed CTD and 1 had polymyositis. Patients in the latter group 
were referred to our institution on suspicion of PAH, because of complaints of exertional 
dyspnoea. 
Patients with tachycardia (> 90 beats/min), systemic hypertension (blood pressure > 140/90 
mmHg), impaired left ventricular systolic function (ejection fraction < 50%), atrial 
fibrillation, tricuspid stenosis or with significant left sided valvular abnormalities were 
excluded from the study.  
The national ethics committee approved the study. All subjects had given written informed 
consent prior to undergoing echocardiography and right heart catheterization. 
 
4.2.3. Echocardiography 
Echocardiography was performed using Aloka ProSound 5500 ultrasound system (Aloka Co. 
Ltd, Tokyo, Japan). Left ventricular ejection fraction was measured by Simpson’s method. 
Right ventricular end-diastolic diameter was obtained from standard parasternal long axis 
view using M-mode measurements. Right ventricular end-systolic and end-diastolic areas 
were measured in apical 4-chamber view. Right ventricular fractional area change (RVFAC) 
was calculated as the difference between the two areas, expressed as the percentage of the 
end-diastolic area. Transmitral and transtricuspid flows were recorded from the apical 4-
chamber view. Peak of the early (E) and late (A) diastolic velocities were measured. Systolic 
pulmonary artery pressure (PAP) was estimated as a sum of the pressure difference across the 
tricuspid valve calculated using the modified Bernoulli equation and an estimate of mean right 
atrial pressure (5 to 15 mmHg) using the diameter and collapse index of the inferior vena 
cava. Myocardial systolic (S), early (E’) and late (A’) diastolic velocities were measured from 
apical 4-chamber view at the lateral border of the mitral and tricuspid annulus using pulsed 
TDI. Tricuspid E/A and mitral E/E’ ratios were calculated. Doppler measurements were 
obtained from ≥ 3 consecutive beats during end-expiratory apnoea.   
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4.2.4. Right heart catheterization 
All patients with CTD underwent right heart catheterization. Echocardiography and 
catheterization were performed within an interval of five days. A 7Fr Swan-Ganz catheter was 
introduced to a main pulmonary artery branch. If the resting mean PAP was lower than 30 
mmHg, a 3 minutes bench-fly physical stress test was performed using two 1-kg dumbbells. 
Mean and systolic and diastolic PAP was measured at rest and at peak exercise. Mean PAP 
>25 mmHg at rest or >30 mmHg at exertion were considered as elevated. PAH was diagnosed 
if at the same time pulmonary capillary wedge pressure was <15 mmHg at rest. 
 
4.2.5. Statistical analysis 
Continuous variables are presented as mean ± SD. Differences between groups were tested 
for significance using analysis of variance (ANOVA). Post hoc tests were performed by 
Bonferroni method. Comparisons of non-parametric data were performed by chi2 tests. A p 
value of < 0.05 was considered as significant. Data were analyzed using SPSS 13.0 statistical 
software (SPSS, Chicago, Illinois).  
To determine the intraobserver variability, one observer analyzed the TDI variables twice, 
blinded to the results of the first measurements. Intraobserver variability was expressed as the 
difference between the measurements/mean of the measurements x 100.  
 
4.3. Results 
13 patients belonging to the CTD-group had resting, while 8 patients had only stress induced 
PAH diagnosed by right heart catheterization (Table 3). Invasively measured mean and 
systolic PAP both showed a strong correlation with the systolic PAP estimated by 
echocardiography (mean PAP: r = 0.685, p<0.001; systolic PAP: r = 0.615, p<0.001).  
Considering the result of the right heart catheterization, CTD patients were divided into the 
following three groups: 24 patients without PAH, 8 patients with stress induced PAH and 13 
patients with resting PAH. Table 4 outlines the principal clinical and echocardiographic 
characteristics of our patient-groups. The four groups were matched in age, gender 
distribution and body surface area. The left ventricular ejection fraction was significantly 
lower in patients with resting PAH than in the other groups, but the difference was clinically 
insignificant. 
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Table 3. Hemodynamic data obtained by right heart catheterization in CTD patients 
 
 
(PCWP: pulmonary capillary wedge pressure; PVR: pulmonary vascular resistance) 
 
In healthy subjects preserved left ventricular diastolic function (E/A>1, normal mitral E’), 
while in CTD patients predominantly impaired relaxation (E/A<1, reduced mitral E’) was 
found. No significant difference was found between mitral E/E’ values in the four groups. 
Diameter of the right ventricle was significantly larger in patients with resting PAH than in 
subjects in the other three groups. 
Based on TDI measurements, in patients with stress induced PAH isolated diastolic right 
ventricular dysfunction was found, while patients with resting PAH had a combination of 
systolic and diastolic dysfunction. Tricuspid E/A and RVFAC results confirmed these 
findings.  
TDI measurements were feasible in all patients. In two patients with CTD prior modification 
of chronotropic therapy was necessary before including to the study by reason of severe 
tachycardia. Intraobserver variability was 0.43 cm/s (4.5%) for tricuspid E’, 0.51 cm/s (3.9%) 
for tricuspid A’ and 0.37 cm/s (2.9%) for tricuspid S. 
 
 
 
 
Patients with CTD (n=45) 
 Without PAH     
(n=24) 
Stress induced PAH 
(n=8) 
Resting PAH  
(n=13) 
Resting mean PAP (mmHg) 18.0±3.2 22.8±1.7 37.9±10.9 
Mean PAP at peak exertion 
(mmHg) 22.4±4.6 39.8±6.3  
PCWP (mmHg) 11.2±3.2 13.9±0.5 13.1±2.1 
PVR (dyn*sec/cm5) 116.8±68.8 137.6±48 351.2±112.0 
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Table 4. Main clinical and echocardiographic characteristics of the study population 
 
 
(BSA: body surface area; EF: ejection fraction; RV: right ventricle; RVFAC: right ventricular 
fractional area change; PASP estimated: systolic pulmonary artery pressure estimated by 
echocardiography; #p<0.05 versus resting PAH; *p<0.01 versus resting PAH; †p<0.001 
versus resting PAH; §p<0.01 versus normal; ‡p<0.001 versus normal) 
Patients with CTD (n=45) 
 
Normal 
subjects 
(n=15) 
Without 
PAH     
(n=24) 
Stress 
induced 
PAH (n=8) 
Resting 
PAH  
(n=13) 
p 
Age (years) 50±6 54±7 58±8 55±8 NS 
BSA (m2) 1.74±0.15 1.76±0.16 1.76±0.14 1.71±0.26 NS 
Male/Female 3/12 3/21 0/8 4/9 NS 
NYHA class 
I 
II 
III 
 
15 
 
 
24 
 
 
8 
 
 
7 
6 
<0.001
Left ventricular EF (%) 63.5±2.3* 61.2±3.3 63.1±2.5# 59.0±3.7 <0.01 
Mitral E/A 1.3±0.4 1.0±0.3 0.9±0.3 1.1±0.3 NS 
Mitral E’ (cm/s) 12.1±2.5 9.9±2.5§ 9.2±1.3§ 9.4±1.4§ <0.01 
Mitral E/E’ 5.9±1.3 7.1±2.4 8.0±1.2 7.9±2.6 NS 
RV diameter (mm) 27.9±2.5† 31.8±4.1* 28.6±3.7† 38.4±8.2 <0.001
RVFAC (%) 56.9±4.6† 53.7±4.1† 54.8±3.7† 41.4±5.5 <0.001
Tricuspid E/A 1.37±0.21 1.20±0.28 0.91±0.17‡ 0.97±0.09‡ <0.001
PASP estimated (mmHg) 24.6±2.4† 30.0±7.0† 32.8±4.5† 52.7±18.7 <0.001
Tricuspid S (cm/s) 13.9±2.6* 13.1±2.7# 12.7±2.1 10.6±2.4 <0.01 
Tricuspid E’ (cm/s) 11.0±1.7 9.7±2.3 8.2±2.2§ 8.4±1.1§ <0.01 
Tricuspid A’ (cm/s) 13.4±3.0 13.7±2.8 12.8±2.4 12.0±3.6 NS 
Tricuspid E’/A’ 0.86±0.25 0.72±0.19 0.67±0.24 0.76±0.22 NS 
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 4.4. Discussion 
Exercise capacity in CTD patients without PAH may be decreased due to skeletal muscle 
involvement, deconditioning or – very often – due to left ventricular diastolic dysfunction.54 
Diastolic dysfunction (predominantly impaired relaxation) was typical in all groups of our 
CTD patients, the left ventricular filling pressure, however, was not elevated.  
Combination of elevated PAP and normal left ventricular filling pressure is characteristic of 
arterial (pre-capillary) pulmonary hypertension, which is a severe, potentially life-threatening 
complication of CTD. The pathophysiologic mechanisms leading to PAH and consequentially 
to right heart dysfunction are thought to be similar in patients with CTD.14-16 
Determination of the tricuspid annular velocities provides an excellent tool for assessing the 
global systolic and diastolic function of the right ventricle. 55-56 The long axis function is 
guided by subendocardial fibres, which are most vulnerable to transitional or permanent 
pressure overload in patients with stress induced or resting PAH. Our results - based on 
invasive and TDI measurements - confirmed the observation of Huez et al .53 suggesting that 
the isolated diastolic dysfunction of the right ventricle is the sign of stress induced pulmonary 
hypertension. In patients with resting elevation of pulmonary artery pressure combined 
systolic and diastolic dysfunction was found. (Figure 2.) The latter observation is in 
accordance with the result reported by Ruan and Nagueh regarding patients with idiopathic 
pulmonary hypertension. 57  
Elevated ventricular pressure, however, is not the only possible cause of the right ventricular 
dysfunction in patients with CTD. Disturbances of myocardial microcirculation and interstitial 
fibrosis as the hallmarks of primary myocardial involvement may also damage the function of 
the subendocardial fibres. 58 Nevertheless, TDI seems to be a promising new method to 
confirm or eliminate suspicion of stress induced pulmonary hypertension in patients with 
connective tissue disease when the non-invasively estimated pulmonary artery pressure is 
normal at rest. 
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Figure 2. Schematic drawing of the tricuspid annular motion (RV) and the typical tissue 
Doppler curve obtained at the tricuspid annulus (TDI) in healthy subjects (A), patients with 
stress induced PAH (B) and in patients with resting PAH (C).   
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5. Echocardiographic particle image velocimetry: a new method to 
determine left ventricular flow pattern 
 
5.1. Introduction 
5.1.1. Intraventricular flow patterns after mitral valve replacement 
The transvalvular flow characteristics of commonly used mitral prosthetic valves are well 
known. 59 The intraventricular vortex formation in relation to the type and orientation of the 
mitral valve prosthesis, however, has not received the same clinical attention. Several factors 
influencing outcomes in mitral valve replacement have been reported. 60-61 Nevertheless, the 
wide variance in postoperative ejection fraction and in survival rate of patient after mitral 
valve replacement remained partially unexplained. To what extent changes in intracavitary 
blood flow patterns contribute could not be measured so far and remains to be determined. 
 
5.1.2. Characterization of flow patterns 
Flow can be described as laminar, vortical, or turbulent. Although laminar flow, which can 
occur in straight blood vessels, is characterized by parallel stream lines, vortical and turbulent 
flows are dominated by swirling motion of the fluid at different scales. In the 15th century, 
Leonardo da Vinci pictured vortices in the sinuses above the aortic valve.62 Until today, 
vortices in the human circulation remain a challenging aspect of fluid dynamics. Modern 
phase-contrast magnetic resonance imaging (MRI) has shown that vortical flow is a common 
finding in the human heart,20, 29-30, 63-64as well as in the great arteries.65-66 Vortices are created 
when the boundary layer of a fluid detaches from a sharp edge.67 In the left ventricle laminar 
mitral inflow is converted into a vortex formation at the tips of the mitral valve leaflets. This 
vortex formation maintains the momentum of the blood and allows smooth redirection of 
blood flow toward the outflow tract during systole with minimal generation of turbulence, 
thus avoiding large losses of kinetic energy.20, 25, 68  
Vortical flow can be characterized by the quantity vorticity (ω) as follows: 
(1)  
y
x
x
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v
v
v
v
∆
∆−∆
∆=ω  
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In a 2-dimensional flow field, vorticity (ω) may be calculated as the difference of the gradient 
of the y-component of the flow velocity in x-direction ⎟⎟⎠
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and the gradient of the x-
component of the flow velocity in y-direction ⎟⎟⎠
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.Therefore, vorticity is positive if a 
vortex rotates counter clockwise; it is negative with clockwise rotation. Laminar flow has a 
zero vorticity (Figure 3.).67 
Because of fluid viscosity, a vortex looses energy. This energy loss is particularly high if there 
are rapid changes in vorticity (high pulsatility) or if many small vortices interact (turbulence). 
In other words, a single, big and steady vortex is an energetically favourable condition, while 
splitting the bloodstream into smaller, rapidly changing vortices is unfavourable:67 Kinetic 
energy gets lost which needs to be provided again by the ventricular musculature. 
Changes in regional vorticity can be used to estimate energy dissipation in the fluid. They 
may be expressed relative to the steady vorticity component in order to obtain a dimensionless 
parameter. This relative strength of the pulsatile component of vorticity can be calculated for 
the entire ventricle (RS) or for the vortex region alone (VRS). RS and VRS are here defined 
as 
(2)  
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where ω0 represents the steady, and ω1 the pulsatile component (first harmonic) of regional 
vorticity.67 
Conceptually similar, but with a different mathematical definition, the vortex pulsation 
correlation (VPC) can be calculated as 
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where ω0 represents again the steady, and ω1 the pulsatile component (first harmonic) of 
regional vorticity, and Avortex the vortex area.67 
 
 
Figure 3. Definition of vorticity in two dimensions. Vorticity is a measure of the curl of 
streamlines (gray lines) of a fluid. According to equation (1), vorticity will be zero (laminar 
flow) if calculated between points 1 and 2, and it will be negative if calculated between points 
2 and 3 (clockwise rotation). (v: flow velocity; vx,vy: x- and y-components of the flow 
velocity) 
 
5.1.3. Particle image velocimetry 
Traditional spectral- or colour Doppler echocardiography measures velocities relative to the 
transducer. Doppler data therefore contain only 1-dimensional information on the blood 
velocity component towards or away from the transducer and do not allow assessment of the 
direction of blood flow. 
Particle image velocimetry (PIV) is a well known principle of determining velocity and 
direction of fluid streams by analyzing the change in position of small particles that drift with 
the fluid to be investigated.69With the recent development of echocardiographic speckle 
tracking technology it is now possible to apply this approach to echocardiographic imaging.6-8 
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Blood flow can be tracked after administration of a low dose of contrast. Intracavitary blood 
flow patterns may then be visualized and quantified in the two dimensions of the image plane. 
In this study we use the new echocardiographic PIV method to investigate the influence of 
mitral valve replacement therapy on blood flow patterns in the left ventricular cavity. 
 
5.2. Materials and methods 
5.2.1. Study Population 
We examined 19 patients (mean age, 57±19 years; 10 female patients). Nine were healthy 
volunteers without signs or symptoms of heart disease. Ten patients had prosthetic mitral 
valves (5 bi-leaflet valves [29-33 mm, St Jude; St Jude Medical, St. Paul, Minnesota] in 
anatomic orientation, 4 bioprostheses [29–33 mm, Carpentier–Edwards; Edwards 
Lifesciences, Irvine, California], and 1 tilting-disc valve [Medtronic Hall, 29 mm; Medtronic, 
Minneapolis, Minnesota] with anterior orientation of the greater orifice). Patients with atrial 
fibrillation, segmental wall motion abnormalities, or impaired left ventricular systolic function 
(regional wall motion abnormalities or ejection fraction<50%) were not included. Six patients 
had medically treated arterial hypertension. The local ethics committee approved the study. 
All subjects provided written informed consent before inclusion. 
 
5.2.2. Echocardiographic image acquisition 
Subjects were imaged in a supine position by using an Acuson Sequoia C512 ultrasound 
system (Siemens Medical Solutions, Mountain View, California). In addition to a standard 
echocardiogram, 2-dimensional greyscale images were acquired with high frame rate (80–
100/s) in all 3 standard apical views and repeated intravenous administration of a low dose of 
left heart contrast (0.1–0.2 ml of SonoVue). The mechanical index was set to 0.5 to 0.8 to 
avoid apical contrast bubble destruction. Images were acquired when cavity contrast 
distribution was homogeneous and single contrast bubbles could be distinguished. Image 
loops of 3 cardiac cycles were digitally stored for subsequent offline analysis. 
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5.2.3. Data Analysis 
Conventional 2-dimensional and Doppler recordings were analyzed during the examination or 
with a dedicated workstation (Syngo, Siemens Medical Solutions, Mountain View, 
California). We measured left ventricular volumes and ejection fractions using a biplane 
Simpson’s approach, as well as left ventricular and left atrial dimensions and the prosthetic 
mitral valve gradient.  
 
5.2.4. Particle image velocimetry 
Echocardiographic loops were processed offline by using a dedicated prototype software 
(Omega Flow Version 2.3.1., Siemens). At first, the endocardial border was manually traced 
in one still frame and then automatically tracked by the software during the cardiac cycle. In a 
second step the so-defined cavity area was analyzed with a feature tracking algorithm. 
Contrast bubbles were assumed to move with the blood flow, and thus tracking them allowed 
us to obtain regional flow information (by means of PIV). Third, the software analyzed the 
left ventricular cavitary flow field and derived parameters to describe flow patterns. The 
maximal vortex area during diastole was given in percentages of the left ventricular area. If 
two vortices were present, the sizes were added. Estimates of energy dissipation (RS, VRS, 
and VPC) were retrieved. Flow patterns were visually assessed by interpreting a field of flow 
velocity vectors superimposed on the grey scale image loops. Colour-coded images visualized 
the flow patterns averaged over the cardiac cycle. 
 
5.2.5. Statistical analysis 
Continuous variables are presented as means ± standard deviations. Differences between two 
groups were tested for significance by using the unpaired t test. For more than two groups, 
analysis of variance (ANOVA) with a Bonferroni post hoc test was used. Contingency tables 
were analyzed with a chi2 test. Mean standard deviations between readings were calculated to 
assess reproducibility of data analysis. Data were analyzed with SPSS 13.0 software (SPSS, 
Inc, Chicago, Illinois). 
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5.3. Results 
5.3.1. Patient data, feasibility, and reproducibility 
Table 5 summarizes the characteristics of our study population. Patients were significantly 
older than the healthy subjects. No significant differences were found between the groups 
regarding sex distribution, body surface area, ejection fraction, or left ventricular end-diastolic 
volume. Left atrial area and mean mitral valve gradient were significantly larger in patients 
with prosthetic mitral valves. 
 
Table 5 Clinical and echocardiographic characteristics of our study population 
  
 
(BSA: body surface area; EDWT: end-diastolic wall thickness; LV: left ventricular; EDV: 
end-diastolic volume; EF: ejection fraction; LA: left atrial; MV: mitral valve) 
 
Because of severe emphysema, acquisition of a 3-chamber view was not possible in one 
patient with a prosthetic mitral valve. Otherwise, offline analysis of left ventricular cavitary 
blood flow patterns was feasible in all subjects. Parameters of vortex area and energy 
dissipation showed low intraobserver variability: standard deviations between three repeated 
readings were 3.7%, 6.0%, 5.7%, and 6.2% for RS, VRS, VPC and vortex area, respectively. 
 Healthy subjects 
(n=9) 
Patients with 
prosthetic MV   
(n=10) 
p 
Age (years) 40±11 72±6 0.000 
BSA (m2) 1.82±0.29 1.81±0.16 0.972 
Male/Female 4/5 5/5 0.808 
EDWT septum (mm) 8.9±1.1 11.7±2.2 0.003 
EDWT lateral wall (mm) 9.3±1.3 11.1±1.3 0.009 
LV EDV/BSA (ml/m2) 52.8±9.1 50.9±8.7 0.643 
LV EF (%) 61.6±6.8 59.7±7.6 0.079 
LA area/BSA (cm2/m2) 9.1±1.3 15.0±2.3 0.000 
Mean MV gradient 
(mmHg) 
0.8±0.3 4.5±2.0 0.000 
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5.3.2. Flow patterns in healthy subjects 
In all healthy subjects, we found a vortex that detaches from the anterior leaflet of the mitral 
valve early after the peak of the E-wave (Figure 4., A). This vortex rotates counter clockwise 
in the 4-chamber view and clockwise in the 3-chamber view and fills almost the entire left 
ventricle by the end of the E-wave (Figure 4., B). With atrial contraction, late mitral inflow is 
directed more laterally and generates a second smaller vortex with equal rotation direction in 
the basal half of the left ventricle (Figure 4., C). With the beginning of systole, the rotating 
blood is redirected toward the outflow tract (Figure 4., D). Laminar flow is noted when blood 
leaves the left ventricle. Figure 4., E and G, shows the spatial vorticity distribution of the left 
ventricle averaged over the cardiac cycle. 
Quantitative parameters of energy dissipation are summarized in Table 6 RS and VPC values 
were significantly lower in healthy hearts than in patients with prosthetic valves, whereas the 
maximal vortex size did not differ between the groups. 
 
5.3.3. Flow patterns of bi-leaflet valves in anatomic orientation 
5.3.3.1. General pattern 
All patients had their bi-leaflet prostheses implanted in anatomic orientation (ie, with the 
hinge positions approximating commissures of the previous native valve). The two outer 
orifices generate jets directed toward the left ventricular septum and the lateral wall. In the 4-
chamber view the contrast bubbles of the septal jet reach the apex first, whereas those of the 
lateral jet travel slower (Figure 5., A). Subsequently, during the deceleration of the E-wave, 
the septal jet becomes dominant (Figure 5., B) and forms a major vortex by the end of the 
diastole, rotating clockwise in the 4-chamber view (Figure 5., C). Thus with the beginning of 
systole, outflowing blood crosses the previous inflow area (Figure 5., D). In general, the 
resulting vorticity pattern in hearts of patients with bi-leaflet valves is opposite to that seen in 
healthy hearts: a large clockwise rotating vortex can be seen in blue in the 4-chamber view 
(Figure 5., E) whereas the 3-chamber view shows a counter clockwise rotating vortex in red 
(Figure 5., G). 
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Figure 4. Flow pattern in a healthy left ventricle. Yellow arrows indicating the instantaneous 
local direction and velocity of blood flow are superimposed on a contrast-enhanced greyscale 
image of a 4-chamber view. A-D, see text for description of the temporal sequence. ECG was 
used as a time reference.  
Normalized regional vorticity in the plane of the 4-chamber view is averaged over the cardiac 
cycle. Counter clockwise rotation of the blood (positive vorticity) is colour-coded in red (E), 
and clockwise rotation is colour-coded (negative vorticity) in blue (G). Schematic drawings of 
the dominating flow path as observed during diastole are shown (F,H). G and H: same display 
as E and F but a 3-chamber view. Note that in images E and F, the central vortex is 
surrounded by a colour rim indicating an opposite vorticity. This is explained by blood 
velocities, which gradually increase from the endocardium toward the vortex structure. Such a 
velocity gradient can be interpreted as vorticity and is thus colour-coded. 
 
 
 
 
 32
 
Figure 5. General flow pattern in patients with bi-leaflet mitral valve prosthesis in anatomic 
orientation. There is a similar display as in Figure 5.2. See the text for a detailed description. 
 
5.3.3.2. Influence of left ventricular geometry 
Two patients with bi-leaflet mitral valve prostheses had a marked midseptal hypertrophy 
(maximal wall thickness, 14 and 15 mm, respectively). In those patients the septal jet did not 
reach the apex directly but was redirected toward the lateral wall by the hypertrophied 
septum. From there, it split into two streams forming two counterrotating vortices: a 
clockwise rotating vortex in the basal half of the ventricle and a second, counter clockwise 
rotating vortex in the apex (Figure 6., A and C, upper panels). With the beginning of systole, 
outflowing blood again crosses the previous inflow area (Figure 6., B, upper panel). Figure 
6., D (upper panel) provides a schematic drawing of the main flow paths. 
Parameters of energy dissipation (RS and VPC) were significantly higher in patients with bi-
leaflet valves than in healthy subjects (Table 6). Compared with patients with bi-leaflet valves 
with the general flow pattern, RS tended to be particularly high in those with altered left 
ventricular geometry (1.98±0.82 vs. 2.85±0.90, p=0.171). 
 33
 
Figure 6. Flow patterns in patients with bi-leaflet valves in anatomic orientation (upper 
panels) and bioprosthetic valves (lower panels), both with marked midseptal hypertrophy. A 
and B, see text for detailed description. ECG was used as a time reference. Normalized 
regional vorticity in the plane of the 4-chamber view is averaged over one cardiac cycle (C). 
Schematic drawings of the dominating flow path as observed during diastole in the 4-chamber 
view are shown (D). 
 
5.3.4. Flow patterns of bioprosthetic valves 
5.3.4.1. General pattern 
The flow through the bioprosthesis generates a central jet directed toward the apex (Figure 7., 
A). It generates a vortex ring that is visualized as a vortex pair in a 2-dimensional image 
(Figure 7., B). With atrial contraction, the same flow pattern is reinforced. At the beginning of 
systole (Figure 7., C), the symmetry of the flow pattern is lost, the posterolateral vortex part 
becomes dominant, and the outflowing blood crosses the previous inflow area again (Figure 
7., D). This dominance of the posterolateral vortex part might also be noted in the time-
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averaged colour-coded representation of left ventricular vorticity from both apical views 
(Figure 7., E and G). 
5.3.4.2. Influence of valve position and left ventricular geometry 
One patient had a marked anteroseptal position of the bioprosthesis, resulting in an inflow jet 
toward the anterior septum. Similar to the abovementioned bi-leaflet valves, this jet is then 
redirected toward the lateral wall by the hypertrophied midseptum (Figure 6., A, lower panel) 
and forms two vortices (Figure 6., B, lower panel). Figure 6., C (lower panel), shows the 
time-averaged vorticity in the 4-chamber view, and Figure 6., D (lower panel), provides a 
schematic drawing of the main flow paths. 
In hearts of patients with bioprosthetic valves, parameters of energy dissipation were higher 
than in hearts of healthy subjects. RS showed a significant difference, and VPC showed a 
trend (Table 6). Energy dissipation was particularly high in the patient with altered left 
ventricular geometry (RS: 2.90±0.48; VPC: 1.76±0.66). 
 
 
Figure 7. General flow pattern in patients with bioprosthetic valves. There is a similar display 
as in Figure 5.2. See the text for a detailed description. 
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5.3.5. Flow pattern of a tilting-disc valve with anterior orientation of the greater orifice 
In our patient with a single-disc prosthesis, the majority of the inflow is directed through the 
greater orifice toward the septum and then redirected by the hypertrophied ventricular septum 
to form a large, clockwise rotating vortex filling the basal two thirds of the ventricle and a 
small, counter clockwise rotating vortex in the anterior apex (Figure 8., A). Similar to the 
other prosthetic valves, the outflowing blood crosses the previous inflow area (Figure 8., B). 
Likewise, parameters of energy dissipation are higher compared with those seen in healthy 
hearts (Table 6). 
 
 
Figure 8. Flow pattern in a patient with a tilting-disc valve with anterior orientation of the 
greater orifice. This is the same principle of display as in Figure 5.4. See the text for a detailed 
description. 
 
5.4. Discussion 
5.4.1. Flow Patterns in Healthy Hearts 
In our study we found vortical flow patterns in the left ventricle, detaching from the mitral 
valve during mitral inflow (Figure 4.). Based on the 2-dimensional data obtained in the three 
apical image planes, we could conclude that a 3-dimensional, torus-like vortex structure 
(similar to a donut or a smoke ring puffed out by a cigarette smoker) enters the left ventricle 
during the beginning of early diastole.  Because of the asymmetry of the left ventricular 
inflow tract, the anteroseptal side of the vortex formation becomes dominant
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Table 6 Characteristics of the left ventricular vortical flow in normal hearts and patients with prosthetic mitral valves 
 
VA – vortex area in % of the left ventricular area. RS, VRS and VPC are parameters of flow pattern dependent energy dissipation in the left 
ventricle: RS - relative pulsatile vorticity strength; VRS - vortex relative pulsatile vorticity strength; VPC - vortex pulsation correlation. See text 
for further details. P-values vs. healthy hearts *) t-test, **) ANOVA post hoc test (Bonferroni) 
 Healthy 
hearts 
All prosthetic 
valves 
p* 
Bi-leaflet 
valves 
p**  
Bioprosthetic 
valves 
p** 
Tilting disc 
valve 
p** 
VA (%) 50.3±5.9 53.5±13.6 0.352 50.6±16.7 1.000  56.9±8.5 1.000 56.2±15.2 1.000 
RS 1.62±0.43 2.36±0.71 0.000 2.33±0.92 0.037  2.43±0.48 0.034 2.28±0.16 0.941 
VRS 0.43±0.10 0.52±0.16 0.052 0.50±0.16 1.000  0.53±0.18 0.828 0.64±0.09 0.315 
VPC 0.72±0.24 1.20±0.51 0.000 1.20±0.60 0.041  1.22±0.49 0.076 1.22±0.29 0.743 
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and persists in the centre of the cavity, leading to the described rotational motion of the 
blood in the ventricle, whereas the smaller posterior part of the vortex diminishes 
rapidly. This is in concordance with prior physical and numeric modelling 21, 23-24, 70 
and supported by in vivo studies with colour Doppler imaging71 and MRI.29-30, 63  
During atrial contraction, we found a more laterally directed mitral inflow forming a 
second vortex structure at the basal half of the ventricle. This is in concordance with 
MRI observations reported by Fyrenius and colleagues,63 who similarly describe two 
different pathways of the inflowing blood during early and late filling. At the very end 
of diastole, a single large vortex is present, and blood is smoothly redirected toward 
the outflow tract for the following systole, as predicted based on numeric modelling by 
others.23, 70  
 
5.4.2. Bi-leaflet valve in anatomic orientation  
The non-physiologic inflow through a bi-leaflet valve leads to a completely different 
and more complex flow pattern in the left ventricle (Figure 5.). In most of our patients, 
the inflow through the septal orifice was dominant and resulted in a major vortex 
rotating in the opposite direction compared with that seen in healthy hearts. This is 
partially supported by prior in vitro simulations 22, 72-73and animal experiments 27, 31, 
74and might be explained by asymmetry of the left ventricular inflow tract. Because the 
septal inflow chamber, which includes the left ventricular outflow tract, is larger than 
the posterior one, the mitral inflow penetrates the ventricle mainly through the septal 
orifice.27 Asynchronous opening of the leaflets22 or asymmetry of the atrial flow20, 64, 73 
might further contribute. 
Our measurements indicate for the first time, that intracavitary blood flow in patients 
with bi-leaflet valve prostheses is less energy efficient than in healthy hearts. Higher 
energy dissipation can be explained by the non-physiologic formation of a major 
vortex rotating in the opposite direction compared with that seen in healthy hearts and 
the outflowing blood crossing the inflow tract during systole. 
Our results show that unfavourable left ventricular geometry further disturbs vortex 
formation. This has not been described previously because experimental studies 
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assume “normal” ventricles. Nevertheless, with the observation of two counterrotating 
vortices in the apical and basal halves of the ventricle, we can show for the first time a 
human in vivo correlate to the colour Doppler patterns described by Van Rijk–Zwikker 
and co-workers27 in pigs. 
 
5.4.3. Bioprosthetic valve 
In concordance with the numeric simulations of Pedrizzetti and Domenichini,25 we 
observed in patients with bioprosthetic valves a completely symmetric inflow pattern 
leading to a symmetric vortex ring (Figure 7.). At the end of diastole, this symmetry is 
lost, and the part of the vortex ring that becomes dominant rotates in the opposite 
direction compared with that seen in healthy hearts. Our data indicate that the flow 
pattern in bioprosthetic valves also results in higher energy dissipation. This might be 
explained by the division of the blood stream in counterrotating parts that leads to a 
higher loss of kinetic energy than in the single vortex of a normal heart. Position of the 
valve and, similar to bi-leaflet prosthesis, left ventricular geometry markedly influence 
the flow pattern. Our data help us understand the previous colour Doppler observations 
of Maire and associates,28 who described unusual flow patterns in patients with an 
eccentric bioprosthetic valve position. 
 
5.4.4. Tilting-disc valve with anterior orientation of the greater orifice 
Our findings in the patient with a tilting-disc prosthesis are in concordance with 
previous Doppler- or MRI-based publications.26, 28, 32 The presence of a hypertrophied 
left ventricular septum explains the formation of the additional counterrotating vortex 
at the apex (Figure 8.). Single tilting-disc prostheses are rarely used in the mitral 
position nowadays. Based on our experiences, however, we hypothesize that the 
normal direction of inflow vortex formation and the separation of inflow and outflow 
tracts might be best simulated by a mitral tilting-disc prosthesis with the larger orifice 
in a posterior orientation.26, 28, 32 To what extent this might counterbalance the 
disadvantages of this type of valve replacement therapy remains to be determined. 
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5.4.5. Clinical considerations 
It has been assumed based on numeric simulations and in vitro and in vivo 
experiments, as well as colour Doppler and MRI measurements, that prosthetic heart 
valves seriously disturb intraventricular flow patterns.21-22, 25-28, 31-32, 72-74The 
application of PIV to echocardiography allows, for the first time, direct visualization 
and, in part, quantification of those patterns and enables estimation of energy 
dissipation in the left ventricle by means of a non-invasive technique. Numeric 
simulations of energy dissipation support the thesis that the natural left ventricle is 
optimized to forward the blood with the lowest energy loss possible.68 A discontinuous 
blood pump can work most efficiently if the momentum of the blood is maintained. A 
linear arrangement of heart chambers would require constant deceleration and 
acceleration of the blood and would waste kinetic energy. In contrast to any linear 
arrangement of heart chambers, it is more energy efficient to have adjacent inflow and 
outflow tracts and a diastolic vortex formation, which stores energy and redirects the 
blood stream while maintaining its kinetic energy.68 
To what extent vortex formation contributes to an optimization of cardiac performance 
is subject to debate.75 Some authors assume that accelerating blood accounts only for 
approximately 2% of the energy consumption of a healthy heart.76Pedrizzetti and 
Domenichini25 showed in a numeric simulation that even slight changes in mitral valve 
position can result in changes of energy dissipation in the range of 15%. A 
counterrotating vortex or more complex flow pattern changes are likely to result in 
even higher energy loss. It might therefore be relevant to optimize intracavitary blood 
flow after valve replacement, particularly in dysfunctional ventricles. We believe that 
this new technique of echocardiographic PIV can contribute to a better understanding 
of hemodynamic consequences of heart valve surgery and thus to an optimization of 
such a therapy. 
 
5.4.6. Limitations of the study 
The current echocardiographic PIV method is 2-dimensional and thus has limits 
regarding the analysis of the 3-dimensional structure of flow patterns. This inherent 
problem of clinical echocardiographic analysis can currently not be solved because of 
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the low temporal and spatial resolution of echocardiographic 3-dimensional imaging 
technology. We are confident, however, that merging information from 3 apical views 
is sufficient to recognize larger 3-dimensional structures in the intracavitary flow of 
the left ventricle. This is supported by the fact that the results of our data interpretation 
are in accordance with mathematic modelling and true 3-dimensional MRI 
measurements of cavitary flow. Future developments in 3-dimensional 
echocardiography might further improve echocardiographic PIV. 
Thus far, flow pattern analysis is descriptive and at best semi-quantitative. The relation 
between flow patterns and energy dissipation is extremely complex and difficult to 
express in a few simple, clinically useful numbers. Further studies are needed to better 
understand these relationships and to offer quantitative measures for intracavitary 
blood flow analysis. 
Ventricular shape changes caused by age, previous mitral valve disease, or removal of 
the subvalvular apparatus were not considered. The study was not powered to 
investigate possible relations between valve size and flow patterns. Our data suggest, 
however, that the presence of a mitral valve prosthesis dominates intracavitary flow 
pattern developments and is only modulated by left ventricular geometry. Outcome 
data are needed to evaluate the clinical relevance of our findings. 
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6. Discussion 
 
6.1. Left atrial size and function are characteristics of chronic left ventricular 
diastolic dysfunction  
BNP and NT-proBNP levels are known to be elevated in patients with HCM and 
correlate with New York Heart Association functional class, left ventricular outflow 
tract gradient and maximal left ventricular wall thickness. 77-80 A close correlation 
between left atrial volume or function and BNP levels has also been reported in HCM 
patients,81 the pathophysiologic background of this relationship, however, is not clear. 
BNP is released from both the ventricular and atrial myocardium in response to 
myocyte stretch and transmural pressure load, still, plasma levels of BNP mainly 
reflect the degree of left ventricular filling pressure. 82 In addition, previous studies 
have shown a strong association between left atrial volume and left ventricular 
diastolic function grade.45-47 These data suggests that the missing link between left 
atrial function and NT-proBNP level may be the left ventricular diastolic function. At 
the same time, in our work and in more studies similarly, Doppler-derived parameters 
of left ventricular diastolic function and filling pressure showed no or very modest 
correlation with the BNP level.81, 83 The explanation of this phenomenon may be, that 
these techniques present only a snapshot view of diastolic function: the pattern would 
be altered if loading conditions changed.84  
On the other hand, the increased left atrial pressure in HCM patients with normal left 
ventricular systolic function and no significant mitral valve disease has been attributed 
to left ventricular diastolic dysfunction. The left atrial size may increase with the 
increase of the left atrial pressure, since the left atrium is a thin-walled structure. The 
left atrium during ventricular diastole is exposed directly to left ventricular pressures 
since the mitral valve is open. After distension, there is only a little elastic recoil in the 
left atrium to respond to the fall in pressure, therefore a chronically dilated left atrium 
does not change in size with transient changes in left atrial pressure. Thus, unlike the 
Doppler measures of left ventricular diastolic dysfunction, the left atrial size is 
independent of loading conditions and correlates with the severity and the time 
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duration of the diastolic dysfunction. Therefore left atrial size may be superior to the 
Doppler-derived parameters in the characterization of left ventricular diastolic 
dysfunction and thus it shows a stronger correlation with the BNP levels. 
Much less data are available in the literature about the deterioration of A’, parallel with 
the impairment of left ventricular diastolic function.85 Our data, however, suggest, that 
the behaviour of the left ventricular size and A’ parameter is similar in patients with 
preserved ejection fraction and diastolic dysfunction, which may explain the 
correlation we have found between NT-proBNP level and A’ parameter in our study.   
 
6.2. Importance of TDI in the assessment of right ventricular function in CTD 
patients 
CTDs are multi-system disorders characterized by extensive involvement of the 
internal organs. Cardiac involvement occurs very often in these patients, manifesting 
as pericardial effusion, valve disease or myocardial fibrosis and resulting in heart 
failure. 
PAH is one of the relatively common complications of CTDs, and finally results in 
right heart failure. The prognosis in these patients correlates with the presence of PAH.  
Mukerjee et al. suggested that the hemodynamic parameters of right ventricular 
dysfunction are strong predictors of outcome in CTD patients.86 Right ventricular 
function, however, is rarely evaluated. This is because of complex chamber geometry 
and lack of objective methods. Traditional methods used to assess right ventricular 
function such as radionuclide ventriculography, magnetic resonance imaging, and the 
thermodilution method of right heart catheterization are time-consuming and relatively 
expensive, and can not be used at the bedside.58  
On the other hand, the development of echocardiography allowed the assessment of the 
right ventricular systolic and diastolic function non-invasively. Traditionally, right 
ventricular systolic function was derived mainly from tricuspid annular displacement, 
while Doppler parameters of the right ventricular filling were used to characterize the 
diastolic function. Recently, TDI of the tricuspid annulus has been shown to be an 
accurate and reproducible representation of global right ventricular systolic and 
diastolic function.55-56 In addition, both systolic and diastolic functional parameters 
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represents a very powerful tool for risk stratification of patients with right heart 
failure.87 
 In our work we described a new application of the early diastolic TDI parameter, 
proving, that it is a promising screening method to confirm or eliminate suspicion of 
stress induced pulmonary hypertension in patients with CTD.  
  
6.3. Flow pattern inside the heart: outlook 
In our study, for the first time, we presented a description of normal intraventricular 
blood flow patterns and their changes caused by mitral valve surgery based on non-
invasive echocardiographic PIV. The technique was feasible in the clinical setting and 
allowed clear differentiation of normal from disturbed flow patterns after mitral valve 
replacement, as well as quantification of left ventricular energy dissipation. 
Future applications of echocardiographic PIV might comprise the study of 
postoperative left ventricular flow characteristics to optimize bioprosthetic and 
mechanical heart valve design. Preoperative PIV could help to select most optimal 
implantation techniques, such as valve replacement with or without preservation of the 
subvalvular apparatus, or to optimize implantation for a specific pathology, such as 
postinfarction patients or hearts with septal hypertrophy. Flow investigations by PIV 
could also improve valve reconstruction strategies or help to optimize other surgical 
cardiovascular interventions, such as Fontan operations. Pathophysiologic knowledge 
could be gained on the relation between left ventricular and left atrial flow 
characteristics and the rate of thromboembolic events. Our results suggest, that 
echocardiographic PIV has potential clinical importance for the analysis of cardiac 
function and guidance of cardiosurgical interventions. 
 
6.4. Conclusion 
Heart failure is an increasing and leading cause of cardiovascular morbidity, 
hospitalisation and death worldwide. Echocardiography is uniquely suited to 
characterize anatomical and functional abnormalities in patients at risk of developing 
heart failure, suspected of having heart failure, and with symptomatic heart failure. 
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Furthermore, echocardiography can provide prognostic information and assist in the 
management of patients with acute, chronic and end-stage heart failure. 
Traditional methods for assessing cardiac morphology, function and hemodynamics, 
however, were insufficient to clarify several challenging problems of heart failure 
patients. Therefore, contemporary imaging techniques in the assessment of heart 
failure patients are moving toward evaluation of myocardial motion and deformation 
or intracavitary flow. 
In our work we used tissue Doppler imaging and particle image velocimetry to 
evaluate specific problems in patients with left ventricular diastolic dysfunction, right 
ventricular dysfunction or prosthetic mitral valves. Our results prove the usefulness of 
the novel echocardiographic techniques in the solution of specific problems in heart 
failure patients. 
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7. Novel findings 
 
7.1. Based on TDI measurement we proved a significant correlation between B-type 
natriuretic peptide level and the left atrial function in patients with hypertrophic 
cardiomyopathy.  
 
7.2. By the help of TDI measurements and right heart catheterisation we confirmed the 
observation, that isolated resting longitudinal diastolic dysfunction of the right 
ventricle is the sign of exercise induced pulmonary hypertension in patients with 
connective tissue diseases. 
 
7.3. Our results demonstrated, that the new method of echocardiographic particle 
image velocimetry is able to describe and distinguish left ventricular flow patterns in 
healthy hearts and in patients with different types of prosthetic mitral valves.  
 
7.4. By the help of echocardiographic particle image velocimetry we proved, that flow-
mediated energy dissipation in the left ventricle is significantly higher in patients with 
prosthetic mitral valves than in healthy subjects. 
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